Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.

Metabolic syndrome is associated with a greater risk for excessive scarring, with several specific metabolic components linked to higher risk.

While no association was observed between use of biologics and incident PsA overall, specific biologic classes were ...

Skyrizi (risankizumab-rzaa) IL-23 inhibitor Treatment of children aged 6 years and older with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy, and for ...

Bemotrizinol, recently approved as a new active ingredient in sunscreens, is the first new ingredient for OTC sunscreen ...

The table below is a review of notable updates that occurred in June 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. BM-3103 ...

Pregnancy may not be a risk factor for invasive melanoma or melanoma in situ, though women of reproductive age may be at an increased risk.